New oral diabetes drug shows promise in early safety trial
NCT ID NCT05086445
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This study tests an experimental oral drug called LY3502970 in Japanese adults with type 2 diabetes. The main goal is to check for side effects and see how the body processes the drug. Participants take either the drug or a placebo and are monitored over up to 24 weeks with blood tests and clinic visits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an experimental oral drug called LY3502970
- What this could lead to
- If successful, this could lead to a new oral medication option for managing blood sugar in people with type 2 diabetes.
- What could go wrong
- This is an early phase 1 trial focused on safety, so it is too soon to know if the drug works well. Side effects are possible and being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Hospital Tokyo
Shinjuku-ku, Tokyo, 162-0053, Japan
-
Medical Corporation Heishinkai OPHAC Hospital
Osaka, Osaka, 532-0003, Japan
-
Medical Corporation Houeikai Sekino Clinical Pharmacology Clinic
Toshima City, Tokyo, 171-0014, Japan
-
P-One Clinic
Hachiōji, Tokyo, 192-0071, Japan
-
Yokohama Minoru Clinic
Yokohama, 232-0064, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Kidney clues may predict eye swelling after cataract surgery in diabetes patients
- AI-Powered trial asks: does adding a second drug cut heart failure risk?
- Scientists hunt for hidden fat molecules that sabotage insulin
- Can a pharmacist check-in boost medication adherence in diabetes and kidney disease?
- Could a simple breathing exercise ease pain and anxiety during nerve testing?
- New injectable drug aims to tame blood sugar in type 2 diabetes